Thymosin Beta-4 (full length)
The full-length parent molecule behind TB-500, with more actual human trial exposure, mostly in eye and cardiac research.
What is Thymosin Beta-4 (full length)?
Thymosin beta-4 is the complete, naturally occurring 43-amino-acid protein that TB-500 is a fragment of. It is one of the most abundant proteins in human cells and a major regulator of the actin cytoskeleton. The reason it earns its own page is evidence: unlike the injected TB-500 fragment, the full-length protein has actually been through human clinical trials, mostly for the eye and the heart.
How Thymosin Beta-4 (full length) works
Thymosin beta-4 is the body's principal G-actin sequestering protein. By binding monomeric actin it controls how the cytoskeleton assembles and disassembles, which in turn governs cell shape and migration. That is the engine behind its repair effects: it helps cells move into injured tissue, promotes new blood-vessel growth, and down-regulates inflammatory chemokines, cytokines, and tissue-degrading enzymes. In short, it is both a cell-migration signal and an anti-inflammatory, anti-fibrotic one.
What the research shows
This is where the full-length protein separates from the fragment. A thymosin beta-4 ophthalmic solution (developed as RGN-259) has been tested in randomized human trials for dry eye and reached a phase 3 trial in neurotrophic keratopathy, showing improved corneal healing and comfort. On the cardiac side, a human randomized trial in patients with acute heart attack did not show a significant overall reduction in infarct size, though a benefit appeared in a subgroup treated very early. So there is genuine human data, but it is concentrated in ophthalmic use, not in the systemic "recovery" use the peptide is often marketed for.
Dosage and how it is used
Because approvals are still pending and the studied formulations differ, there is no standardized general-use dose. The strongest human evidence used topical ophthalmic solutions at defined concentrations, which is very different from a systemic injection. Any injectable protocol for general recovery is outside what the clinical trials tested and is not standardized.
→ How to reconstitute Thymosin Beta-4 (full length): calculator, units to draw & storage
Side effects and safety
In the ophthalmic trials, thymosin beta-4 was generally well tolerated. That is more human safety exposure than most peptides on this list can claim, but it is specific to the eye formulation and does not automatically transfer to systemic injection. Broader long-term safety is still not established, it is not broadly approved, and, like TB-500, it sits on the World Anti-Doping Agency prohibited list for tested athletes.
- Research depth: moderate, with real human trials. Best evidence is ophthalmic.
- Well tolerated in eye studies; systemic long-term safety not established.
- Banned in tested sport (WADA). Not broadly approved. Verify current status independently.
Frequently asked questions
What is the difference between thymosin beta-4 and TB-500?
Thymosin beta-4 is the full 43-amino-acid natural protein. TB-500 is a synthetic peptide built from its active actin-binding region. The full-length protein has more direct human clinical research, mostly in eye and cardiac studies, while injected TB-500's evidence is mostly preclinical.
Does thymosin beta-4 have human clinical trials?
Yes. A thymosin beta-4 ophthalmic solution has been through randomized human trials for dry eye and a phase 3 trial in neurotrophic keratopathy, and it has been studied in a human heart-attack trial. Most of the strong data is ophthalmic.
Is thymosin beta-4 approved?
Not broadly. It has been studied clinically, especially as an eye treatment, but it is not a widely approved general-use medication, and systemic use for recovery is outside what the trials tested.
Is thymosin beta-4 banned in sports?
Yes. Like TB-500, it appears on the World Anti-Doping Agency prohibited list and is not permitted in tested competition.
References
Track Thymosin Beta-4 (full length) in Peptide AI
Log your doses, connect labs and wearables, and let the AI show you how Thymosin Beta-4 (full length) is affecting your biomarkers over time.
Download the appEducational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.